CN109280078A - 一种制备维拉卡肽的方法 - Google Patents
一种制备维拉卡肽的方法 Download PDFInfo
- Publication number
- CN109280078A CN109280078A CN201811277081.4A CN201811277081A CN109280078A CN 109280078 A CN109280078 A CN 109280078A CN 201811277081 A CN201811277081 A CN 201811277081A CN 109280078 A CN109280078 A CN 109280078A
- Authority
- CN
- China
- Prior art keywords
- arg
- pbf
- resin
- ala
- wella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811277081.4A CN109280078B (zh) | 2018-10-30 | 2018-10-30 | 一种制备维拉卡肽的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811277081.4A CN109280078B (zh) | 2018-10-30 | 2018-10-30 | 一种制备维拉卡肽的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109280078A true CN109280078A (zh) | 2019-01-29 |
CN109280078B CN109280078B (zh) | 2019-06-25 |
Family
ID=65174913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811277081.4A Active CN109280078B (zh) | 2018-10-30 | 2018-10-30 | 一种制备维拉卡肽的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109280078B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112062811A (zh) * | 2019-06-10 | 2020-12-11 | 深圳翰宇药业股份有限公司 | 一种维拉卡肽的合成方法 |
TWI792442B (zh) * | 2021-07-23 | 2023-02-11 | 建誼生技股份有限公司 | 依特卡肽鹽酸鹽之製造方法 |
CN116947966A (zh) * | 2023-09-18 | 2023-10-27 | 哈药集团生物工程有限公司 | 一种伊特卡肽中间体及伊特卡肽的制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105504012A (zh) * | 2014-09-30 | 2016-04-20 | 深圳翰宇药业股份有限公司 | 一种多肽的制备方法 |
WO2016154580A1 (en) * | 2015-03-26 | 2016-09-29 | Amgen Inc. | Solution phase method for preparing etelcalcetide |
CN106795201A (zh) * | 2014-04-03 | 2017-05-31 | 美国安进公司 | 用于制备amg416的方法 |
CN106928321A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 一种合成Etelcalcetide的方法 |
CN106928320A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 一种合成Etelcalcetide的方法 |
CN107434820A (zh) * | 2017-08-07 | 2017-12-05 | 南京工业大学 | 一种维拉卡肽的合成方法 |
CN108218957A (zh) * | 2016-12-21 | 2018-06-29 | 四川科伦药物研究院有限公司 | 一种固液相结合制备amg416的方法 |
-
2018
- 2018-10-30 CN CN201811277081.4A patent/CN109280078B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106795201A (zh) * | 2014-04-03 | 2017-05-31 | 美国安进公司 | 用于制备amg416的方法 |
CN105504012A (zh) * | 2014-09-30 | 2016-04-20 | 深圳翰宇药业股份有限公司 | 一种多肽的制备方法 |
WO2016154580A1 (en) * | 2015-03-26 | 2016-09-29 | Amgen Inc. | Solution phase method for preparing etelcalcetide |
CN106928321A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 一种合成Etelcalcetide的方法 |
CN106928320A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 一种合成Etelcalcetide的方法 |
CN108218957A (zh) * | 2016-12-21 | 2018-06-29 | 四川科伦药物研究院有限公司 | 一种固液相结合制备amg416的方法 |
CN107434820A (zh) * | 2017-08-07 | 2017-12-05 | 南京工业大学 | 一种维拉卡肽的合成方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112062811A (zh) * | 2019-06-10 | 2020-12-11 | 深圳翰宇药业股份有限公司 | 一种维拉卡肽的合成方法 |
CN112062811B (zh) * | 2019-06-10 | 2022-03-25 | 深圳翰宇药业股份有限公司 | 一种维拉卡肽的合成方法 |
TWI792442B (zh) * | 2021-07-23 | 2023-02-11 | 建誼生技股份有限公司 | 依特卡肽鹽酸鹽之製造方法 |
CN116947966A (zh) * | 2023-09-18 | 2023-10-27 | 哈药集团生物工程有限公司 | 一种伊特卡肽中间体及伊特卡肽的制备方法 |
CN116947966B (zh) * | 2023-09-18 | 2023-12-26 | 哈药集团生物工程有限公司 | 一种伊特卡肽中间体及伊特卡肽的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109280078B (zh) | 2019-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102428097B (zh) | 地加瑞克的制造方法 | |
CN104987382B (zh) | 一种二肽片段液固结合制备胸腺法新的方法 | |
CN109280078B (zh) | 一种制备维拉卡肽的方法 | |
CN106928320B (zh) | 一种合成Etelcalcetide的方法 | |
CN105384809B (zh) | 一种片段法固液结合制备特立帕肽的方法 | |
WO1998011125A1 (en) | Improved solid-phase peptide synthesis and agent for use in such synthesis | |
CN103180335B (zh) | 用于制备地加瑞克及其中间体的方法 | |
CA1201710A (en) | Analgesic compounds | |
US10577394B2 (en) | Ganirelix precursor and method for preparing ganirelix acetate by using the same | |
CN101104638B (zh) | 胸腺素α1的固相合成工艺 | |
CN103709243B (zh) | 一种制备利西拉来的方法 | |
CN105504012A (zh) | 一种多肽的制备方法 | |
CN110054662B (zh) | 一种固相合成Etelcalcetide的方法 | |
CN104072585A (zh) | 一种合成艾替班特的方法 | |
CN106554391B (zh) | 一种海洋生物肽Xen2174的合成方法 | |
CN104177490A (zh) | 片段缩合制备醋酸鲑鱼降钙素的方法 | |
CN106478805A (zh) | 一种glp-1衍生物的制备方法 | |
CN104211801A (zh) | 一种制备利西拉来的方法 | |
CN103665115A (zh) | 环十肽化合物gg-110824的化学制备方法 | |
CN109354608A (zh) | 一种基于Fmoc二肽的合成阿拉瑞林的方法 | |
WO2021103458A1 (zh) | 一种地加瑞克的固相合成方法 | |
CN102875643B (zh) | 用于合成生长抑素的主要肽片段 | |
CN110563812A (zh) | 一种醋酸加尼瑞克的制备方法 | |
CN104447979B (zh) | 一种制备奈西利肽的方法 | |
CN110386964A (zh) | 一种亮丙瑞林的固液合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Yuanbo Inventor after: Zhong Guoqing Inventor after: Zhu Yongzhou Inventor after: Long Xiaofang Inventor after: Gan Yujuan Inventor after: Zhang Jiali Inventor after: Gao Jian Inventor before: Li Yuanbo Inventor before: Zhong Guoqing Inventor before: Zhu Yongzhou Inventor before: Long Xiaofang Inventor before: Qian Yujuan Inventor before: Zhang Jiali Inventor before: Gao Jian |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Yuanbo Inventor after: Zhong Guoqing Inventor after: Long Xiaofang Inventor after: Gan Yujuan Inventor after: Zhang Jiali Inventor after: Gao Jian Inventor before: Li Yuanbo Inventor before: Zhong Guoqing Inventor before: Zhu Yongzhou Inventor before: Long Xiaofang Inventor before: Gan Yujuan Inventor before: Zhang Jiali Inventor before: Gao Jian |